Live Feeds

Source map — Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
CNBC news 60%
PR Newswire news 60%
Axios news 60%
qz.com news 60%
Seeking Alpha news 60%
houstonchronicle.com news 60%
TradingView news 60%
TipRanks news 60%
Investing.com news 60%
KHOU news 60%
Reuters news 60%
www.eli.edu news 50%
www.prnewswire.com news 50%
www.onedaymd.com news 50%
www.accio.com news 50%
pharmaphorum.com news 50%
peptidestaff.com news 50%
health.yahoo.com news 50%
247wallst.com news 50%
www.bioxconomy.com news 50%
www.healthyoneapp.com news 50%
beebulletin.com news 50%
www.ibj.com news 50%
sterlingcharts.com news 50%
pharma.economictimes.indiatimes.com news 50%
www.biocentury.com news 50%
www.glp1authority.com news 50%
www.youtube.com news 50%
en.wikipedia.org news 50%
www.onedayadvisor.com news 50%
www.fool.com news 50%
biblehub.com news 50%
www.eli.org news 50%
elireview.com news 50%
www.gotquestions.org news 50%
www.biospace.com news 50%
www.el-fondo.com news 50%
biotechresearch.co.uk news 50%
rocketnews.com news 50%
www.cnbc.com news 50%
abc13.com news 50%
finance.yahoo.com news 50%